Has Roger Schechter, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,317 in general payments to Roger Schechter, MD across 114 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Roger Schechter, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Roger Schechter, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Roger Schechter, MD

Emergency Medicine · Escondido, CANPI 1346257649

Payments from drug & device makers

$18,317in general payments, 2019–2025

Across 114 payments — averaging $160.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Organogenesis Inc.$11K
Merz North America, Inc.$6K
Smith+Nephew$169
Integra Lifesciences Corporation$150
Mylan Specialty L.p.$125
Musculoskeletal Transplant Foundation Inc.$61
plus $113 from 3 others

What the payments were for

Speaking & faculty fees$9,98655%
Travel & lodging$8455%
Food & beverage$7,48641%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Organogenesis Inc.	26	$11,227
Merz North America, Inc.	77	$6,473
Smith+Nephew	3	$169
Integra Lifesciences Corporation	2	$150
Mylan Specialty L.p.	1	$125
Musculoskeletal Transplant Foundation Inc.	1	$61
Kerecis Limited	1	$52
AbbVie	2	$46
Galderma Laboratories, L.p.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,317 in reported general payments places this provider in the 95th percentile of 6,006 emergency medicine providers in California.

See all emergency medicine providers in California →

Medicare billing

Part B allowed, 2024

$84,111

Medicare patients

108

Services billed

701

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Monohydrate	15	$319

Paid to pharmacies, not to this prescriber.

Other emergency medicine in Escondido

Todd SimmonsEscondido$19.9M
Amanda HoldenEscondido$103K
Steven MannisEscondido$100K
Jeffrey OvercashChula Vista$31.8M
Michael WatersChula Vista$13.3M
Barry HellerLong Beach$11.5M
Gregory HachigianSacramento$10.9M
Masaru OshitaSacramento$7.9M
Brian BearieSan Bernardino$6.5M
Julie KasarjianRiverside$4.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →